Cullinan Therapeutics, Inc. CGEM
- CLN-049 — Acute Myeloid Leukemia Phase 2
- CLN-049 — Myelodysplastic Syndrome Phase 1
FLT3 (4 companies · 5 programs)
Companies with an active program directed at FLT3.
Allogene Therapeutics, Inc. ALLO
- ALLO-819 — Acute Myeloid Leukemia
Biomea Fusion, Inc. BMEA
- BMF-500 — Acute Myeloid Leukemia Phase 1
Kura Oncology, Inc. KURA
- KOMZIFTI — Acute Myeloid Leukemia Approved